ASND

Summary

Hold ASND at ~264.05. Do not chase unconfirmed 6.5% intraday spike. Require settled close above Bollinger upper 261.79 and 50 SMA 255.53 on 500-600k+ final volume before any scale-in. If confirmed, add only half-size due to ATR 8.15 (8-12 point stop below 255.53/VWMA 251.38). Hedge ISDS Week 104 binary (IV 54.4%, P/C vol 0.96) with collar/protective put; no naked long into data. Time horizon 5 days tactical hold, fundamental validation needs Q2 revenue >246.6M and OCF turning positive.

The case

Our analysis finds the long-term trend intact (price >200 SMA 231.28, MACD bullish cross 0.59, RSI 61.73 with headroom) and the BioMarin settlement removes injunction tail risk for Yuviwel (first/only once-weekly achondroplasia, FDA March), but near-term risk/reward at 264.05 is poor. Fundamentals: 144% YoY growth masks sequential stall (Q1 246.6M vs Q4 247.5M -0.36%), pre-tax -48M after 67.3M interest on 896M debt, OCF -7.7M, TTM FCF 12.7M = 0.07% yield on 17.3B cap, working capital -4.4M with receivables +36M to 196M and inventory +12.8M to 314M. 27.94x forward P/E prices perfection net of new 20% US /18% EU royalty drag to 2030 that compresses 92.9% gross margin; 20.25x TTM P/E is distorted by 677.5M DTA. Operating income +24.8M for 3 quarters, equity repair to +488M (D/E 1.8x) and 812M cash removes distress, and the 2030 royalty cliff is long-term upside to 315-345 targets, but that does not compensate for 2026-2029 cash drag. Technicals: provisional bar above 50 SMA 255.53 after 6 days below and 2.26 above Bollinger 261.79 on partial 374k volume is not confirmation; VWMA 251.38 <50 SMA shows volume anchored lower, false-breakout risk to intraday low 247.65 (ATR 8.15 with 12% to 200 SMA and elevated daily noise). Sentiment confirms hedged bullish: P/C vol 0.96 parity with IV 54.4% elevated into Week 104 ISDS binary, P/C OI 0.55 structural long but near-term protection buying, social sentiment channels only 3/30 ticker-native bullish, confidence 64, a market fear gauge at 50 neutral. We avoid acting on unfinished prints and front-running headline risk without level break. Hold reflects no edge: upside to 268-282/345 requires confirmed close and durable Week 104 data; downside is uncompensated volatility and cash conversion failure. Own = hold, flat = wait.

What would weaken it

• Week 104 ISDS binary volatility, IV 54.4% elevated
• Cash conversion failure: OCF -7.7M, FCF yield 0.07%
• False breakout risk to 247.65 on weak volume